Diagnostic proteomics: will this impact the clinic?
نویسنده
چکیده
Sascha Sauer Over the last decades we have witnessed enormous progress in the life sciences in terms of in-depth knowledge but less in the development of groundbreaking new concepts. Modern life sciences are dominated by application of the very successful reductionist research paradigm of experimental physics and chemistry [1]. However, experimental manipulation and simple mechanistic interpretation may turn out to be inadequate in biology when dealing with interconnected and inherently non-separable processes, leading to technical or even fundamental limitations due to biological uncertainty of the various states of interacting molecules [2]. Recently, systematic data driven approaches were introduced to generate in a largely unbiased fashion hypotheses, and in the ideal case to monitor the expression and regulation of all relevant molecular key players such as proteins. However, complexity may in particular arise from causality structures [3], which cannot be easily deduced from the “parts of the sum” of single molecules and mechanistic interaction of a few key players. It seems that network-based interaction of molecules results in the important redundancy, plasticity and flexibility of biological systems including homeostatic regulation of the proteome, which would otherwise be too vulnerable to environmental perturbation or stochastic events [4]. The advent of new methodologies in the life sciences including proteomics raised hope to provide efficient tools for diagnosis and for monitoring of complex disease (treatments) [5]. But the transition of proteomics-based research to clinical practice is in general still inefficient. Clinical proteomics as other fields of the life sciences dealing with complex issues may benefit from developing innovative approaches, i.e. to adequately grasp the etiology and causality of diseases to eventually develop fruitful approaches and tools for efficient diagnostics and medication of diseases. In this Focus Issue on “Diagnostic Proteomics”, a number of concepts, methodologies and promising results are presented to advance the field of clinical proteomics. In a viewpoint, Ulrich Stelzl (contribution in this issue, pp. 727–732) discusses the importance of molecular networks for interpreting various large data sets including genetic variation and proteomics data, to better understand fundamental biological organisation principles and to comprehensively analyse disease processes [6]. During the last years, biological mass spectrometry based methods have been introduced for various potential clinical applications. For example, mass spectrometry based imaging methods have become promising tools to analyze on the molecular level the pathology of tissue samples [7]. Jeremy Norris and Richard Caprioli (contribution in this issue, pp. 733–738) provide a concise update on these methods and discuss future applications. Furthermore, protein-based diagnostic markers can be identified in discovery-driven approaches using high-throughput mass spectrometers [8]. In this context, Bruno Domon and co-workers (contribution in this issue, pp. 739–747) discuss newest developments in the field of (targeted) mass spectrometry (also [9]) to validate potential protein-based biomarkers for final application in diagnostic test systems such as ELISA. Clearly, all these endeavours in clinical proteomics and related fields would be useless without making well-organised efforts in standardising clinical samples for biomarker development and validation using genomics, proteomics or other modern methodologies [10]. In a Standardisation & Guidelines paper Gil Omenn (contribution in this issue, pp. 748–755) describes current efforts to establish solid grounds in this crucial field. Furthermore, it is well known that many research and diagnostic methods heavily rely on the use of well-validated protein binding molecules such as antibodies [11]. In a review, Mike Taussig and co-workers (contribution in this issue, pp. 756–766) give a thorough overview to guide the readers through the world of protein binders, which are key components of many diagnostic technologies. Recently, facile, robust and standardized mass spectrometry based methods have been successfully implemented in hundreds of microbiology laboratories. In particular MALDI-TOF
منابع مشابه
Sperm chromatin: fertile grounds for proteomic discovery of clinical tools.
Sperm are remarkably complex cells with a singularly important mission: to deliver paternal DNA and its associated factors to the oocyte to start a new life. The integrity of sperm DNA is a keystone of reproductive success, which includes fertilization and embryonic development. In addition, the significance in these processes of proteins that associate with sperm DNA is increasingly being appr...
متن کاملPharmaceutical Advances and Proteomics Researches
Proteomics enables understanding the composition, structure, function and interactions of the entire protein complement of a cell, a tissue, or an organism under exactly defined conditions. Some factors such as stress or drug effects will change the protein pattern and cause the present or absence of a protein or gradual variation in abundances. Changes in the proteome provide a snapshot of the...
متن کاملBioinformatics Meets Clinical Informatics
The field of bioinformatics has exploded over the past decade. Hopes have run high for the impact on preventive, diagnostic, and therapeutic capabilities of genomics and proteomics. As time has progressed, so has our understanding of this field. Although the mapping of the human genome will certainly have an impact on health care, it is a complex web to unweave. Addressing simpler "Single Nucle...
متن کاملPharmaceutical Advances and Proteomics Researches
Proteomics enables understanding the composition, structure, function and interactions of the entire protein complement of a cell, a tissue, or an organism under exactly defined conditions. Some factors such as stress or drug effects will change the protein pattern and cause the present or absence of a protein or gradual variation in abundances. Changes in the proteome provide a snapshot of the...
متن کاملUnderstanding the Pathological Basis of Neurological Diseases Through Diagnostic Platforms Based on Innovations in Biomedical Engineering: New Concepts and Theranostics Perspectives
The pace of advancement of genomics and proteomics together with the recent understanding of the molecular basis behind rare diseases could lead in the near future to significant advances in the diagnosing and treating of many pathological conditions. Innovative diagnostic platforms based on biomedical engineering (microdialysis and proteomics, biochip analysis, non-invasive impedance spectrosc...
متن کاملProteomics Applications in Health: Biomarker and Drug Discovery and Food Industry
Advancing in genome sequencing has greatly propelled the understanding of the living world, however, it is insufficient for full description of a biological system. Focusing on, proteomics has emerged as another large-scale platform for improving the understanding of biology. Proteomic experiments can be used for different aspects of clinical and health sciences such as food technology, biomark...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Proteomics. Clinical applications
دوره 7 11-12 شماره
صفحات -
تاریخ انتشار 2013